As the Ebola outbreak continues to spread, Uganda has tightened its border controls with the Democratic Republic of Congo, where the outbreak originated. The latest development comes as pharmaceutical companies, including Moderna, are racing to develop an mRNA vaccine for the rare Bundibugyo virus driving the current outbreak. According to reports, Moderna and others are working tirelessly to develop a vaccine, with the aim of conducting clinical trials in the near future. The Ugandan government has also increased its efforts to prevent the spread of the disease, with health authorities reporting 676 confirmed cases, including 136 deaths, in the Democratic Republic of Congo. The outbreak has sparked widespread concern, with many experts warning of the need for a coordinated international response to contain the disease. As the situation continues to unfold, Uganda's efforts to develop a vaccine and tighten border controls are seen as crucial steps in preventing the spread of the disease.
On top of everything as it happens